[Prognostic markers of multiple sclerosis]

Area of Science:

• Neurology
• Immunology
• Medical Research

Background:

• Multiple sclerosis (MS) is a heterogeneous chronic autoimmune disease.
• Prognosis is key for patient decisions but often undiscussed.
• Current clinical markers offer limited prognostic detail.

Purpose of the Study:

• To review prognostic markers in multiple sclerosis.
• To explore clinical, neuroimaging, and biological factors.
• To enhance personalized MS prognosis prediction.

Main Methods:

• Literature review of prognostic studies in MS.
• Analysis of clinical, neuroimaging, and biological markers.
• Focus on research and clinical trial applications.

Main Results:

• Clinical markers provide general prognostic information.
• Neuroimaging and biological markers show research potential.
• These advanced markers are increasingly used in clinical trials.

Conclusions:

• A comprehensive understanding of prognostic markers is needed.
• Personalized prognosis aids patient planning in MS.
• Further research integrating diverse markers is essential.